An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension

K. N. Chowta, M. N. Chowta, P. Bhat, Pmr Adhikari

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives : To compare the efficacy and safety of losartan with enalapril, in mild to moderate hypertension. Methods : An open, enalapril controlled study was conducted in 30 patients with mild to moderate hypertension. Losartan 50 mg was administered to patients for eights weeks. Throughout the study blood pressure was measured every two weeks. Routine laboratory investigations were performed before entering the trial, fourth week and at the end of the study. Adverse effects were recorded. After eight weeks losartan was stopped and enalapril 10 mg daily was administered to the same patients after two weeks washout period. The same methodology that was followed for losartan trial was repeated for enalapril trial also. Results : Losartan treatment resulted in a highly significant reduction in the mean sitting diastolic blood pressure. Comparison with enalapril showed that both drugs are equally efficacious in reducing blood pressure in mild to moderate hypertension. The percentage of responders was slightly more with losartan than enalapril (86.7% vs 76.7%). Adverse events reported with losartan were mild. Enalapril also was well tolerated like losartan but there was high incidence of dry cough, which was reported in nine patients (30%). Conclusions : Losartan is an effective antihypertensive drug with an excellent safety and tolerability profile. It shows similar blood pressure lowering efficacy to that of enalapril. In contrast to enalapril, losartan does not cause dry cough.

Original languageEnglish
Pages (from-to)1236-1239
Number of pages4
JournalJournal of Association of Physicians of India
Volume50
Issue number10
Publication statusPublished - 01-10-2002

Fingerprint

Enalapril
Losartan
Clinical Trials
Hypertension
Safety
Blood Pressure
Cough
Antihypertensive Agents

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{c0f6ea8c34174cedbf952a247b3ea19b,
title = "An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension",
abstract = "Objectives : To compare the efficacy and safety of losartan with enalapril, in mild to moderate hypertension. Methods : An open, enalapril controlled study was conducted in 30 patients with mild to moderate hypertension. Losartan 50 mg was administered to patients for eights weeks. Throughout the study blood pressure was measured every two weeks. Routine laboratory investigations were performed before entering the trial, fourth week and at the end of the study. Adverse effects were recorded. After eight weeks losartan was stopped and enalapril 10 mg daily was administered to the same patients after two weeks washout period. The same methodology that was followed for losartan trial was repeated for enalapril trial also. Results : Losartan treatment resulted in a highly significant reduction in the mean sitting diastolic blood pressure. Comparison with enalapril showed that both drugs are equally efficacious in reducing blood pressure in mild to moderate hypertension. The percentage of responders was slightly more with losartan than enalapril (86.7{\%} vs 76.7{\%}). Adverse events reported with losartan were mild. Enalapril also was well tolerated like losartan but there was high incidence of dry cough, which was reported in nine patients (30{\%}). Conclusions : Losartan is an effective antihypertensive drug with an excellent safety and tolerability profile. It shows similar blood pressure lowering efficacy to that of enalapril. In contrast to enalapril, losartan does not cause dry cough.",
author = "Chowta, {K. N.} and Chowta, {M. N.} and P. Bhat and Pmr Adhikari",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "50",
pages = "1236--1239",
journal = "The Journal of the Association of Physicians of India",
issn = "0004-5772",
publisher = "Journal of Association of Physicians of India",
number = "10",

}

TY - JOUR

T1 - An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension

AU - Chowta, K. N.

AU - Chowta, M. N.

AU - Bhat, P.

AU - Adhikari, Pmr

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Objectives : To compare the efficacy and safety of losartan with enalapril, in mild to moderate hypertension. Methods : An open, enalapril controlled study was conducted in 30 patients with mild to moderate hypertension. Losartan 50 mg was administered to patients for eights weeks. Throughout the study blood pressure was measured every two weeks. Routine laboratory investigations were performed before entering the trial, fourth week and at the end of the study. Adverse effects were recorded. After eight weeks losartan was stopped and enalapril 10 mg daily was administered to the same patients after two weeks washout period. The same methodology that was followed for losartan trial was repeated for enalapril trial also. Results : Losartan treatment resulted in a highly significant reduction in the mean sitting diastolic blood pressure. Comparison with enalapril showed that both drugs are equally efficacious in reducing blood pressure in mild to moderate hypertension. The percentage of responders was slightly more with losartan than enalapril (86.7% vs 76.7%). Adverse events reported with losartan were mild. Enalapril also was well tolerated like losartan but there was high incidence of dry cough, which was reported in nine patients (30%). Conclusions : Losartan is an effective antihypertensive drug with an excellent safety and tolerability profile. It shows similar blood pressure lowering efficacy to that of enalapril. In contrast to enalapril, losartan does not cause dry cough.

AB - Objectives : To compare the efficacy and safety of losartan with enalapril, in mild to moderate hypertension. Methods : An open, enalapril controlled study was conducted in 30 patients with mild to moderate hypertension. Losartan 50 mg was administered to patients for eights weeks. Throughout the study blood pressure was measured every two weeks. Routine laboratory investigations were performed before entering the trial, fourth week and at the end of the study. Adverse effects were recorded. After eight weeks losartan was stopped and enalapril 10 mg daily was administered to the same patients after two weeks washout period. The same methodology that was followed for losartan trial was repeated for enalapril trial also. Results : Losartan treatment resulted in a highly significant reduction in the mean sitting diastolic blood pressure. Comparison with enalapril showed that both drugs are equally efficacious in reducing blood pressure in mild to moderate hypertension. The percentage of responders was slightly more with losartan than enalapril (86.7% vs 76.7%). Adverse events reported with losartan were mild. Enalapril also was well tolerated like losartan but there was high incidence of dry cough, which was reported in nine patients (30%). Conclusions : Losartan is an effective antihypertensive drug with an excellent safety and tolerability profile. It shows similar blood pressure lowering efficacy to that of enalapril. In contrast to enalapril, losartan does not cause dry cough.

UR - http://www.scopus.com/inward/record.url?scp=0036825181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036825181&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 1236

EP - 1239

JO - The Journal of the Association of Physicians of India

JF - The Journal of the Association of Physicians of India

SN - 0004-5772

IS - 10

ER -